quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:18:22·7h
INSIDERFiling
Charter Communications Inc. logo

Director Conn Lance was granted 918 shares, increasing direct ownership by 12% to 8,465 units (SEC Form 4)

CHTR· Charter Communications Inc.
Telecommunications
Original source

Companies

  • CHTR
    Charter Communications Inc.
    Telecommunications

Recent analyst ratings

  • Jan 13UpdateWells Fargo$180.00
  • Nov 4UpdateOppenheimer-
  • Nov 3UpdateKeyBanc Capital Markets-
  • Nov 3UpdateBernstein$280.00
  • Oct 6UpdateCitigroup$325.00
  • Sep 2UpdateGoldman$223.00

Related

  • INSIDER7h
    Director Zinterhofer Eric Louis was granted 2,019 shares, increasing direct ownership by 4% to 53,601 units (SEC Form 4)
  • INSIDER7h
    Director Wargo J David was granted 918 shares, increasing direct ownership by 134% to 1,602 units (SEC Form 4)
  • INSIDER7h
    Director Slaski Carolyn J was granted 918 shares, increasing direct ownership by 64% to 2,346 units (SEC Form 4)
  • INSIDER7h
    Director Emeritus Rutledge Thomas exercised 1,627,560 shares at a strike of $227.11, covered exercise/tax liability with 1,574,809 shares and was granted 1,407 shares, increasing direct ownership by 279% to 73,601 units (SEC Form 4)
  • INSIDER7h
    Director Ramos Mauricio was granted 918 shares, increasing direct ownership by 11% to 9,380 units (SEC Form 4)
  • INSIDER7h
    Director Patterson Martin Edward was granted 918 shares, increasing direct ownership by 134% to 1,602 units (SEC Form 4)
  • INSIDER7h
    Director Newhouse Michael A was granted 918 shares, increasing direct ownership by 17% to 6,181 units (SEC Form 4)
  • INSIDER7h
    Director Nair Balan was granted 1,407 shares, increasing direct ownership by 15% to 11,029 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022